IBEX Technologies Inc V.IBT

Healthcare Biotechnology

IBEX Technologies Inc., through its wholly owned subsidiary, IBEX Pharmaceuticals Inc., manufactures and markets enzymes for biomedical use. IBEX Pharmaceutical Inc.’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The Company also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research. The Company has developed a proprietary expression for the production of its enzymes in Flavobacterium heparinum. This expression system allows for producing each glycosaminoglycan (GAG) enzyme separately from other enzymes therefore achieving the highest purity using a well-defined proprietary purification scheme. The Company operates in one industry segment: the production and sale of diagnostic products.

TSXV:IBT - Post by User

IBEX Technologies Inc > Chondroitinaise, Heparinase use in Cancer Detection Dec 2022

<< Previous

Bullboard Posts

Next >>

Comment by guarantor1on May 29, 2023 5:19pm

89 Views

Post# 35469288

RE:Chondroitinaise, Heparinase use in Cancer Detection Dec 2022

An innovative, noninvasive test could detect cancer in early stages,

was from
https://www.medicalnewstoday.com/articles/an-innovative-noninvasive-test-could-detect-cancer-in-early-stages

and from Ibex's website

IBEX produces a family of high purity recombinant glycosaminoglycan (GAG) lyases; among them Chondroitinase AC and Chondroitinase B (as well as Heparinase I, Heparinase II, Heparinase III).

The IBEX chondroitinases are widely used in research and as quality control reagents.

IBEX has developed a proprietary Flavobacterium heparinum expression system which produces glycosylated enzymes exactly the same as GAGS produced from the native strain, but with less cross-contaminating GAG enzymes

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects